Dr. Gary R. Pasternack, MD, PhD serves as Chief Executive Officer of Asklepion Pharmaceuticals, LLC. Dr. Pasternack serves as a Principal of Intralytix, Inc. Dr. Pasternack is a Partner of Aqua Partners. He is the Founder of two Baltimore companies, Intralytix, Inc., and Culterra, LLC. Dr. Pasternack serves as a Director of the Division of Molecular Pathology and of the Graduate Program in Pathobiology at the Johns Hopkins University School of Medicine. He serves as a Principal in a number of biotechnology businesses. He is the Founder and Board Chair of The Ingenuity Project. He is an inventor on over ten issued U.S. patents, and consults actively in the biotechnology, pharmaceutical, and financial communities. In 1984, he returned to Baltimore. After earning his MD and PhD degrees from The Johns Hopkins University School of Medicine in 1978, he trained in Pathology and Anatomic Pathology at Yale.